<DOC>
	<DOCNO>NCT02368613</DOCNO>
	<brief_summary>The purpose study evaluate adequate-dose DW-3102 treatment hypercholesterolemia patient conduct phase 2a . 4 group involve placebo group , group compose 16 , participate trial .</brief_summary>
	<brief_title>A Clinical Trial Evaluation Adequate Dose Safety DW-3102 Hypercholesterolemia Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>More 19 year old Those meet fasting serum lipid level along table Those 350 mg/dL TG level fast The patient acute arterial disease The patient severe heart failure ( NYHA class III IV ) Within last 6 month clinically meaningful treatment require arrhythmias cardiac conduction disorder Uncontrolled hypertension ( systolic blood pressure ≥ 180mmHg diastolic blood pressure ≥ 110mmHg later ) Endocrine metabolic disease patient know affect serum lipid lipoproteins Fibromyalgia , myopathy , rhabdomyolysis , sudden muscle pain past , statin ( HMG CoA reductase inhibitor ) patient muscle related adverse drug experience system Drug malabsorption gastrointestinal surgery experience ( simple appendectomy hernia surgery exclude ) gastrointestinal disorder ( Crohn 's disease , ulcer , acute chronic pancreatitis , etc . ) Patients history malignancy include leukemia lymphoma within past five year If severe renal impairment patient impair liver hematological finding follow Patients participate another clinical trial within previous 30 day Prior administration least five time halflife active ingredient elapse patient IND Those know hypersensitivity hyperlipidemia treatment Patients hypersensitivity allergy cruciferous plant Patients history drug alcohol abuse within last 12 month Female patient childbearing age In case male test subject , spouse agree use childbearing age woman work , recognize contraception exclusion criterion present Section 15 Patient inappropriate investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>